Filtros de búsqueda

Lista de obras de Silvio Danese

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations

artículo científico publicado en 2016

685 Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study

764 Results of Andante, a Randomized Clinical Study With an Anti-IL6 Antibody (PF-04236921) in Subjects With Crohn's Disease Who Are Anti-TNF Inadequate Responders

A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis

scientific article published on 30 May 2019

A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis

artículo científico publicado en 2019

A practical guide for faecal calprotectin measurement: myths and realities

artículo científico publicado en 2020

A snapshot of the ongoing clinical research on COVID-19

artículo científico publicado en 2020

Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures

scientific article published on 26 August 2020

Accuracy of Diffusion-weighted Magnetic Resonance Imaging in Detecting Mucosal Healing and Treatment Response, and in Predicting Surgery, in Crohn's Disease

scientific article published on 01 November 2018

Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study.

artículo científico publicado en 2018

Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer

artículo científico publicado en 2019

Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases

artículo científico publicado en 2017

Acute small-bowel perforation secondary to capsule endoscopy

artículo científico publicado en 2007

Adalimumab and Azathioprine Combination Therapy for Crohn's Disease: A Shining Diamond?

artículo científico publicado en 2016

Adalimumab for the treatment of pediatric Crohn's disease

artículo científico

Adalimumab in active ulcerative colitis: a "real-life" observational study

artículo científico publicado en 2013

Adalimumab in ulcerative colitis: hypes and hopes

artículo científico publicado en 2011

Adalimumab is effective in achieving clinical and endoscopic long-term deep remission: A case report

Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials

artículo científico publicado en 2020

Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting

artículo científico publicado en 2017

Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.

artículo científico publicado en 2010

Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease

artículo científico publicado en 2013

All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis

scientific article published on 16 July 2019

Alterations of mesenchymal and endothelial cells in inflammatory bowel diseases

artículo científico publicado en 2006

An unusual case of cardiac involvement in Crohn's Disease

artículo científico publicado en 2020

Anaemia from a patient perspective in inflammatory bowel disease: results from the European Federation of Crohn's and Ulcerative Colitis Association's online survey

artículo científico publicado en 2014

Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries.

artículo científico publicado en 2013

Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease.

artículo científico publicado en 2018

Anemia in Inflammatory Bowel Disease: The Opening of Pandora's Box?

artículo científico publicado en 2015

Angiogenesis as a novel component of inflammatory bowel disease pathogenesis.

artículo científico publicado en 2006

Angiogenesis blockade as a new therapeutic approach to experimental colitis

artículo científico publicado en 2006

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial.

artículo científico publicado en 2017

Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's Profile

artículo científico publicado en 2019

Anti-TNF Therapy in Inflammatory Bowel Diseases

Anti-TNF and Postoperative Complications in Abdominal Crohn's Disease Surgery

artículo científico publicado en 2019

Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach

scientific article published on 26 July 2019

Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?

scientific article published on 01 January 2019

Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go.

scientific article published on 12 February 2008

Anti-fibrotic Drugs for Crohn's Disease: Ready for Prime Time?

scientific article published on 01 January 2019

Antibody to alpha4beta7 integrin for ulcerative colitis

scientific article published on 01 September 2005

Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement

scientific article published on 15 April 2020

Application of Artificial Intelligence to Gastroenterology and Hepatology

artículo científico publicado en 2019

Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality?

scientific article published on 19 November 2020

Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases

scientific article published on 19 June 2019

Are Surgical Rates Decreasing in the Biological Era In IBD?

scientific article published on 01 January 2019

Are We Ready to Abandon Placebo in Randomised Clinical Trials for Inflammatory Bowel Disease? Pros and Cons

artículo científico publicado en 2016

Assessment and grading of mucosal inflammation in colonic diverticular disease

artículo científico publicado en 2008

Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases.

artículo científico publicado en 2013

Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials

artículo científico publicado en 2020

Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study

artículo científico publicado en 2020

Author Correction: Crohn's disease

scientific article published on 20 May 2020

Author Correction: Crohn's disease

scientific article published on 19 June 2020

Author Correction: Head-to-head trials in inflammatory bowel disease: past, present and future

scientific article published on 05 January 2021

Author Correction: Management of IBD during the COVID-19 outbreak: resetting clinical priorities

scientific article published on 06 May 2020

Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial

artículo científico

Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response.

artículo científico publicado en 2012

Balanced propofol sedation administered by nonanesthesiologists: The first Italian experience

artículo científico publicado en 2011

Balancing risks and benefits in inflammatory bowel disease patients during the COVID-19 pandemic

scientific article published on 15 May 2020

Big data in IBD: a look into the future

artículo científico publicado en 2019

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.

artículo científico publicado en 2016

Biologic agents for IBD: practical insights

artículo científico

Biologic therapies in ulcerative colitis: primi inter pares?

artículo científico publicado en 2016

Biological agents for moderately to severely active ulcerative colitis: a systematic review and network meta-analysis

artículo científico publicado en 2014

Biological agents for ulcerative colitis: hypes and hopes

artículo científico publicado en 2008

Biological therapies for inflammatory bowel disease: research drives clinics.

artículo científico publicado en 2006

Biological therapy for ulcerative colitis: what is after anti-TNF.

scientific article published on September 2011

Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough?

scientific article published on 01 November 2017

Biosimilar and Originator Product in Inflammatory Bowel Diseases: Mind the Gap?

scientific article published on 01 January 2019

Biosimilar switching in inflammatory bowel disease: from evidence to clinical practice

scientific article published on 21 September 2020

Biosimilar therapies in inflammatory bowel disease: should we care about patient profile?

artículo científico publicado en 2016

Biosimilars for the management of inflammatory bowel diseases: economic considerations

artículo científico publicado en 2017

Biosimilars in IBD: from theory to practice

artículo científico publicado en 2016

Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?

artículo científico publicado en 2019

Biosimilars of adalimumab: the upcoming challenge in IBD

artículo científico publicado en 2019

Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial target

artículo científico publicado en 2014

Bowel Damage as Assessed by the Lémann Index is Reversible on Anti-TNF Therapy for Crohn’s Disease

artículo científico publicado en 2015

Bowel damage assessment in Crohn's disease by magnetic resonance imaging

artículo científico publicado en 2012

Budesonide MMX Add-on to 5-Aminosalicylic Acid Therapy in Mild-to-Moderate Ulcerative Colitis: A Favourable Risk-Benefit Profile.

artículo científico publicado en 2017

Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis

artículo científico publicado en 2015

Budesonide: teaching an old dog new tricks for inflammatory bowel disease treatment

scientific article published on January 2008

CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration

scientific article published on 01 January 2004

CD40L-positive platelets induce CD40L expression de novo in endothelial cells: adding a loop to microvascular inflammation

artículo científico publicado en 2004

Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials

artículo científico publicado en 2016

Can IL-23 be a good target for ulcerative colitis?

artículo científico publicado en 2018

Catching the therapeutic window of opportunity in early Crohn's disease.

artículo científico

Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study

artículo científico publicado en 2017

Challenges in the Pathophysiology, Diagnosis and Management of Intestinal Fibrosis in Inflammatory Bowel Disease

artículo científico publicado en 2019

Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease

artículo científico

Changes in Biosimilar Knowledge among European Crohn's Colitis Organization [ECCO] Members: An Updated Survey.

artículo científico publicado en 2016

Changes in inflammatory bowel disease patients' perspectives on biosimilars: A follow-up survey

artículo científico publicado en 2019

Characteristics Of Lymphoma In Patients With Inflammatory Bowel Disease: A Systematic Review

scientific article published on 19 September 2020

Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review

artículo científico

Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease

artículo científico publicado en 2020

Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic

artículo científico publicado en 2020

Clinical course of COVID-19 in 41 patients with immune-mediated inflammatory diseases: experience from Humanitas Center, Milan

artículo científico publicado en 2020

Clinical development of biologicals and biosimilars - safety concerns

scientific article published on 05 May 2017

Clinical pharmacists and patients with inflammatory bowel diseases: are we ready for the multidisciplinary approach?

artículo científico publicado en 2021

Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic

artículo científico publicado en 2020

Clinical, endoscopic and histological outcomes in induction of moderate-to-severe ulcerative colitis: a systematic review with meta-analysis

artículo científico publicado en 2020

Clinician Education and Adoption of Preventive Measures for COVID-19: A Survey of a Convenience Sample of General Practitioners in Lombardy, Italy

scientific article published on 15 April 2020

Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies

scientific article published on 01 June 2009

Colitis, microbiota, and colon cancer: an infernal triangle

scientific article published on 20 December 2012

Colitis-associated cancer: the dark side of inflammatory bowel disease

artículo científico publicado en 2011

Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).

artículo científico

Colorectal cancer prevention in patients with ulcerative colitis

artículo científico publicado en 2018

Colorectal cancer screening: dying en route?

artículo científico publicado en 2010

Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis

artículo científico publicado en 2014

Comorbidities in inflammatory bowel disease: a call for action

artículo científico publicado en 2019

Comparative Accuracy of Bowel Ultrasound Versus Magnetic Resonance Enterography in Combination With Colonoscopy in Assessing Crohn’s Disease and Guiding Clinical Decision-making

artículo científico publicado en 2018

Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease

scientific article published on 22 April 2020

Comparative assessment of budesonide-MMX and mesalamine in active, mild-to-moderate ulcerative colitis: A systematic review and network meta-analysis

artículo científico publicado en 2019

Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis.

artículo científico publicado en 2017

Comparing histological activity indexes in UC.

artículo científico publicado en 2014

Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn's disease

artículo científico publicado en 2013

Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development

scientific article published on 26 October 2018

Comparison of two methods for the in-vivo diagnosis of Helicobacter pylori infection using a tablet of 13C-urea

artículo científico publicado en 2017

Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?

artículo científico publicado en 2014

Confounding and bias in observational studies in inflammatory bowel disease: a meta-epidemiological study

scientific article published on 09 December 2020

Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART) approach

Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients

scientific article published on 01 April 2019

Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

scientific article published on 02 June 2020

Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease

artículo científico publicado en 2020

Corrigendum to "Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease" [Dig. Liver Dis. 48 (2016) 360-370]

article

Corrigendum: Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease

artículo científico publicado en 2018

Corrigendum: Perception of Reproductive Health in Women with Inflammatory Bowel Disease

artículo científico publicado en 2019

Cost-effectiveness of biological treatment sequences for fistulising Crohn's disease across Europe.

artículo científico publicado en 2017

Covid-19 digestive system involvement and clinical outcomes in a large academic hospital in Milan, Italy

scientific article published on 10 May 2020

Crohn’s disease

artículo científico publicado en 2020

Cross-sectional imaging modalities in Crohn's disease

artículo científico

Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease.

artículo científico publicado en 2007

Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification

artículo científico publicado en 2004

Cytapheresis in inflammatory bowel diseases: current evidence and perspectives

artículo científico publicado en 2008

Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease

artículo científico publicado en 2020

Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions

artículo científico publicado en 2016

Dendritic cells, TGF-beta, and Integrin alphavbeta8 in inflammatory bowel disease: a tolerogenic "ménage à trois"

artículo científico publicado en 2008

Detection and management of early stage inflammatory bowel disease: an update for clinicians

artículo científico publicado en 2019

Development and validation of the Nancy histological index for UC.

artículo científico publicado en 2015

Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative

artículo científico

Development of an index to define overall disease severity in IBD.

artículo científico publicado en 2016

Development of drugs to target interactions between leukocytes and endothelial cells and treatment algorithms for inflammatory bowel diseases

artículo científico

Development of the Crohn's disease digestive damage score, the Lémann score

artículo científico publicado en 2010

Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.

artículo científico publicado en 2014

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process

artículo científico

Diagnostic Delay in Crohn's Disease: Time for Red Flags

artículo científico publicado en 2016

Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management

scientific article published on 08 April 2020

Diffusion-weighted MRI in inflammatory bowel disease

artículo científico publicado en 2018

Digestive Diseases. Introduction.

artículo científico publicado en 2014

Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER database

artículo científico publicado en 2015

Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study

artículo científico publicado en 2016

Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD "AGED study".

artículo científico publicado en 2016

Disease-related and drug-induced skin manifestations in inflammatory bowel disease.

artículo científico publicado en 2017

Does anti-TNF therapy cost so many COINs?

artículo científico publicado en 2013

Does the mucosal microcirculation play a role in IBD?

scientific article published on 01 October 2008

Dose optimization is effective in ulcerative colitis patients losing response to infliximab: a collaborative multicentre retrospective study.

artículo científico publicado en 2013

Drug Development for Inflammatory Bowel Disease: Interaction Among Academia, Industry and Regulatory Authorities

artículo científico publicado en 2016

Drug development in IBD: from novel target identification to early clinical trials

artículo científico publicado en 2016

Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease

artículo científico publicado en 2020

E-health in inflammatory bowel diseases: More challenges than opportunities?

artículo científico publicado en 2017

ECCO Position Paper: Harmonisation of the approach to Ulcerative Colitis Histopathology

artículo científico publicado en 2020

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update

artículo científico publicado en 2016

ECCO position statement: the use of biosimilar medicines in the treatment of inflammatory bowel disease (IBD).

artículo científico publicado en 2013

EMA response to ECCO position statement on biosimilars

artículo científico publicado en 2014

Early Combined Immunosuppression in Crohn's Disease: Acting Rather Than REACTing

artículo científico publicado en 2016

Early Intervention in Ulcerative Colitis: Ready for Prime Time?

artículo científico publicado en 2020

Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy

artículo científico publicado en 2020

Early combined immunosuppression in Crohn's disease

artículo científico publicado en 2008

Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study.

artículo científico publicado en 2012

Early intervention in Crohn's disease: towards disease modification trials

artículo científico publicado en 2017

Editorial. Imaging inflammatory bowel disease: looking beyond the mucosa

artículo científico publicado en 2012

Editorial. Medical challanges in inflammatory bowel disease: quo vadis in disease complexity?

artículo científico publicado en 2014

Editorial: CCR7 is required for leukocyte egression in an experimental model of Crohn's disease-like ileitis

scientific article published on 01 June 2015

Editorial: Personalized Medicine in Inflammatory Bowel Diseases: Myth or Reality?

artículo científico publicado en 2018

Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors’ reply

artículo científico publicado en 2018

Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply.

artículo científico publicado en 2018

Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA.

artículo científico publicado en 2017

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

artículo científico publicado en 2017

Effect of tumor necrosis factor-α blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease

artículo científico publicado en 2013

Effectiveness Research in Inflammatory Bowel Disease: A Necessity and a Methodological Challenge

artículo científico publicado en 2016

Effectiveness of Infliximab Biosimilar in Crohn's Disease: A Dime, A Dozen

artículo científico publicado en 2019

Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting

artículo científico publicado en 2017

Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study

artículo científico publicado en 2016

Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence

artículo científico publicado en 2018

Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis

artículo científico publicado en 2020

Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study*

artículo científico publicado en 2011

Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignancies

artículo científico publicado en 2010

Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study

artículo científico publicado en 2017

Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis

scientific article published on 28 August 2019

Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses

artículo científico publicado en 2019

Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open

artículo científico publicado en 2019

Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic review

artículo científico publicado en 2010

Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

artículo científico publicado en 2016

Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study

artículo científico publicado en 2019

Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease

artículo científico publicado en 2010

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.

artículo científico publicado en 2017

Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease

scientific article published on 30 April 2020

Efficacy of tumour necrosis factor antagonists in stricturing Crohn's disease: A tertiary center real-life experience

artículo científico publicado en 2017

Efficacy of vedolizumab in fistulising Crohn's disease: Exploratory analyses of data from GEMINI 2.

artículo científico publicado en 2018

Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner?

scientific article published on February 2010

Emerging therapeutic targets and strategies in Crohn's disease

artículo científico publicado en 2016

Emerging therapies for the treatment of ulcerative colitis

artículo científico publicado en 2020

Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes.

artículo científico publicado en 2009

Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease

scientific article published on 04 July 2019

Endoscopy after surgery in inflammatory bowel disease: Crohn's disease recurrence and pouch surveillance

artículo científico publicado en 2020

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period

scientific article published on 16 April 2020

Endothelial Cell-Immune Cell Interaction in IBD.

artículo científico publicado en 2016

Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature.

artículo científico publicado en 2011

Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.

artículo científico publicado en 2006

Environmental Risk Factors for Inflammatory Bowel Diseases: an Umbrella Review of Meta-analyses

Environmental, Nutritional, and Socioeconomic Determinants of IBD Incidence: A Global Ecological Study

artículo científico publicado en 2020

Epithelial NEMO links innate immunity to chronic intestinal inflammation

artículo científico publicado en 2007

Etiopathogenesis of inflammatory bowel diseases

artículo científico publicado en 2006

Etrolizumab in ulcerative colitis: tightening leukocyte traffic control in the inflamed mucosa.

artículo científico publicado en 2014

European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases

artículo científico publicado en 2014

Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents

artículo científico publicado en 2017

Evolution of infliximab biosimilar in inflammatory bowel disease: from intravenous to subcutaneous CT-P13

artículo científico publicado en 2020

Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective

scientific article published on 01 February 2020

Evolving strategies and goals of treatment in ulcerative colitis

artículo científico publicado en 2018

Evolving therapeutic goals in ulcerative colitis: towards disease clearance

artículo científico publicado en 2020

Evolving treatment algorithms in Crohn's Disease

artículo científico publicado en 2016

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

artículo científico publicado en 2016

Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease

artículo científico publicado en 2016

Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease

artículo científico publicado en 2017

Extraintestinal manifestations in inflammatory bowel disease.

artículo científico publicado en 2005

FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents

artículo científico publicado en 2013

Familial aggregation in inflammatory bowel disease: is it genes or environment?

artículo científico publicado en 2011

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

scientific journal article

Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1

artículo científico publicado en 2019

Fecal calprotectin for the diagnosis of bowel inflammation in patients with rheumatological diseases: a systematic review

artículo científico publicado en 2019

Filgotinib in Crohn’s Disease: JAK Is Back

artículo científico publicado en 2017

First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?

artículo científico

Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease

scientific article published on 01 February 2018

Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.

artículo científico publicado en 2015

Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice

artículo científico publicado en 2007

Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle

artículo científico publicado en 2008

Gastrointestinal involvement attenuates COVID-19 severity and mortality

scientific article published on 09 September 2020

Genetic and nutritional predictors of hyperhomocysteinemia in inflammatory bowel disease

artículo científico publicado en 2002

Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project

artículo científico publicado en 2012

Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases

artículo científico publicado en 2018

Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance

artículo científico publicado en 2005

Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences

artículo científico publicado en 2019

Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis

artículo científico publicado en 2016

Head-to-head trials in inflammatory bowel disease: past, present and future

artículo científico publicado en 2020

Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer

artículo científico publicado en 2004

Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features

artículo científico publicado en 2006

Herpes zoster and vaccination strategies in inflammatory bowel diseases: a practical guide

artículo científico publicado en 2020

High prevalence of celiac disease in patients with lactose intolerance

artículo científico publicado en 2005

High rate of helicobacter pylori re-infection in patients affected by type 1 diabetes

scientific article published on 01 August 2002

Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy

scientific article published on 10 September 2020

Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure

scientific article published on 01 February 2020

Histological healing: should it be considered as a new outcome for ulcerative colitis?

scientific article published on 10 January 2020

Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.

artículo científico publicado en 2005

IBD in 2013: enriching the therapeutic armamentarium for IBD.

artículo científico publicado en 2013

IBD: Mucosal healing--EXTENDing our knowledge in Crohn's disease

artículo científico publicado en 2012

IBD: To switch or not to switch: that is the biosimilar question

artículo científico publicado en 2017

IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy

artículo científico publicado en 2017

Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn’s Disease

article

Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study

scientific article published on 01 March 2019

Imaging modalities for perianal Crohn's disease.

artículo científico

Immune and nonimmune components orchestrate the pathogenesis of inflammatory bowel disease ⬇️

artículo científico publicado el 13 de enero de 2011

Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation

artículo científico publicado en 2007

Impact of therapies on bowel damage in Crohn's disease

scientific article published on 20 February 2020

Improving quality of care in endoscopy of inflammatory bowel disease: can we do better?

artículo científico publicado en 2020

Improving the quality of surveillance colonoscopy in inflammatory bowel disease

scientific article published on 01 December 2019

In the Presence of Conceptual Heterogeneity, Results of Network Meta-analysis Comparing Therapies in Crohn's Disease Need to Be Interpreted With Caution

article

Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts

scientific article published on 30 April 2020

Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients

artículo científico publicado en 2012

Infection risk with biologic therapy in patients with inflammatory bowel disease

artículo científico publicado en 2017

Inflammation and coagulation in inflammatory bowel disease: The clot thickens

artículo científico publicado en 2006

Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience

artículo científico publicado en 2020

Inflammatory bowel disease management during the COVID-19 outbreak: a survey from the European Crohn's and Colitis Organization (ECCO)

artículo científico publicado en 2020

Inflammatory bowel disease: estimates from the global burden of disease 2017 study

scientific article published on 29 October 2019

Inflammatory bowel disease: the role of environmental factors

artículo científico publicado en 2004

Inflammatory bowel diseases and COVID-19: the invisible enemy

scientific article published on 16 April 2020

Inflammatory bowel diseases and psychological issues: A new approach for a systematic analysis of the academic debate

artículo científico publicado en 2013

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection

artículo científico publicado en 2016

Infliximab Therapy Inhibits Inflammation-Induced Angiogenesis in the Mucosa of Patients With Crohnʼs Disease

scientific article published on 01 March 2011

Infliximab and azathioprine for Crohn's disease: a super-sonic combination?

artículo científico publicado en 2010

Infliximab biosimilar CT-P13 for inflammatory bowel disease

artículo científico publicado en 2018

Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission

artículo científico publicado en 2013

Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.

artículo científico publicado en 2010

Integrated models of care in managing inflammatory bowel disease: a discussion

artículo científico

Integrins and adhesion molecules as targets to treat inflammatory bowel disease

artículo científico

Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?

scientific article published on 01 January 2019

Internet use among inflammatory bowel disease patients: an Italian multicenter survey

artículo científico publicado en 2009

Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis.

artículo científico publicado en 2014

Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

artículo científico publicado en 2016

Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac disease.

artículo científico publicado en 2010

Iron deficiency: the hidden miscreant in inflammatory bowel disease.

artículo científico publicado en 2014

Is Mesalamine Effective for the Induction of Remission in Crohn's Disease?

artículo científico publicado en 2017

Is it Crohn's disease?

artículo científico publicado en 2020

Is there a role for therapeutic sphingolipids in inflammatory bowel disease?

artículo científico publicado en 2019

JAK inhibition in inflammatory bowel disease

artículo científico publicado en 2017

JAK inhibitors: Novel developments in management of ulcerative colitis

scientific article published on 01 February 2018

JAK or GUT Selectivity: Tipping the Balance for Efficacy and Safety in Ulcerative Colitis

artículo científico publicado en 2020

JAK selectivity: more precision less troubles

artículo científico publicado en 2020

Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials

artículo científico publicado en 2018

Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis

artículo científico publicado en 2020

Knowledge of 5-aminosalicylic acid nephrotoxicity and adherence to kidney function monitoring of patients with inflammatory bowel disease

scientific article published on 30 November 2020

Laparoscopic surgery for recurrent Crohn's disease

artículo científico publicado en 2012

Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study

artículo científico publicado en 2019

Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply

artículo científico publicado en 2020

Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients

artículo científico publicado en 2017

Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply

scientific article published on 01 June 2020

Leukoapheresis in Crohn's disease: the final curtain?

artículo científico

Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease

artículo científico publicado en 2010

Liver tests abnormalities in COVID-19: trick or treat?

artículo científico publicado en 2020

Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease

artículo científico publicado en 2017

Long-term Efficacy of Vedolizumab for Crohn's Disease

artículo científico publicado en 2016

Long-term Efficacy of Vedolizumab for Ulcerative Colitis

artículo científico publicado en 2016

Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis

artículo científico publicado en 2014

Long-term safety of approved biologics for ulcerative colitis

scientific article published on 22 May 2020

Long-term safety of vedolizumab for inflammatory bowel disease

scientific article published on 02 September 2020

Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn's Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis

artículo científico publicado en 2018

Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11

artículo científico publicado en 2019

MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice

artículo científico publicado en 2017

MRI in Crohn's disease--current and future clinical applications

artículo científico publicado en 2011

Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic

artículo científico publicado en 2020

Management of gastrointestinal and liver diseases during pregnancy

artículo científico

Management of patients with complex perianal fistulas in Crohn's disease: Optimal patient flow in the Italian clinical reality

artículo científico publicado en 2019

Management of patients with inflammatory bowel disease and spondyloarthritis

artículo científico publicado en 2017

Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a

artículo científico publicado en 2020

Medical therapy versus surgery in moderate-to-severe ulcerative colitis

artículo científico publicado en 2020

Medico-surgical Management: A Solid Therapeutic Pillar for Improved Patients' Outcomes in Inflammatory Bowel Diseases

artículo científico publicado en 2019

Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme

artículo científico publicado en 2014

Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine

artículo científico publicado en 2015

Mesenchymal stromal cells in inflammatory bowel disease: conspirators within the 'colitogenic niche'?

artículo científico publicado en 2012

Meta-Analysis of the Association Between Anti-Tumour Necrosis Factor Use and Lymphoma Risk in Patients With Inflammatory Bowel Disease: Methodological Considerations

scientific article published on 01 November 2018

Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease

scientific article published on 25 September 2018

Metal stents for malignant colorectal obstruction

artículo científico publicado en 2006

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

artículo científico publicado en 2015

Microscopic features of colorectal neoplasia in inflammatory bowel diseases

artículo científico publicado en 2014

Milan Ultrasound Criteria are accurate in assessing disease activity in ulcerative colitis: External validation

artículo científico publicado en 2020

Modern use of 5-aminosalicylic acid compounds for ulcerative colitis

scientific article published on 18 September 2019

Modulation of sphingosine-1-phosphate in ulcerative colitis

artículo científico publicado en 2020

Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment

artículo científico publicado en 2009

Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?

artículo científico publicado en 2010

Multicentre Cohort Study to Evaluate the Need for Re-Intervention following Multimodal Treatment in Croh<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" altimg="si1.gif" overflow="scroll"><mml:mover><mml:mtext>n</mml:mtext><mml:mo>`</mml:mo>

artículo científico publicado en 2017

Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group

scientific article published on 04 December 2019

Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial

artículo científico publicado en 2015

Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades

artículo científico publicado en 2008

NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer

artículo científico publicado en 2019

Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study

artículo científico publicado en 2010

Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.

artículo científico publicado en 2016

New Insights into Inflammatory Bowel Disease Pathophysiology: Paving the Way for Novel Therapeutic Targets

artículo científico publicado en 2008

New Paradigms to Help Decisions in Treatment Choice: Head to Head Trial of Biological Therapies in Inflammatory Bowel Diseases

scientific article published on 11 December 2020

New drugs in the pipeline for the treatment of inflammatory bowel diseases: what is coming?

artículo científico publicado en 2020

New mechanisms and targets for IBD Therapy: translational gastroenterology comes of age.

artículo científico publicado en 2013

New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease

artículo científico publicado en 2015

New therapeutic avenues in ulcerative colitis: thinking out of the box.

artículo científico publicado en 2013

Next generation of small molecules in inflammatory bowel disease.

artículo científico publicado en 2016

Nocebo effect and biosimilars in inflammatory bowel diseases: what's new and what's next?

artículo científico publicado en 2020

Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohn's Disease

artículo científico publicado en 2019

Novel Targets for Therapeutic Intervention in Inflammatory Bowel Disease: Research Drives Clinic

scientific article published on 01 January 2019

Novel therapeutic targets for inflammatory bowel disease

artículo científico

Of mice and men—shedding new light on IL-13 activity in IBD ⬇️

artículo científico publicado el 8 de febrero de 2011

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

artículo científico publicado en 2013

Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic

scientific article published on 19 May 2020

Oral beclomethasone: a review of its use in inflammatory bowel disease

scientific article published on December 2008

Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study

artículo científico publicado en 2020

Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study

scientific article published on 15 June 2020

PAI-1 and TAFI in inflammatory bowel disease: the yin and yang of the fibrinolytic system

artículo científico publicado en 2008

PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue

artículo científico publicado en 2017

PF-00547659 for the treatment of Crohn's disease and ulcerative colitis

artículo científico publicado en 2018

PK, PD and interactions: the new scenario with JAK inhibitors and S1P Receptor Modulators, two classes of small molecule drugs, in IBD

artículo científico publicado en 2020

Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-α agents

artículo científico

Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis Associations

artículo científico publicado en 2016

Patient and physician views on the quality of care in inflammatory bowel disease: Results from SOLUTION-1, a prospective IG-IBD study

Patient's profiling for therapeutic management of inflammatory bowel disease: a tailored approach

scientific article published on 19 May 2020

Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

scientific article published on 31 October 2020

Perception of Reproductive Health in Women with Inflammatory Bowel Disease.

artículo científico publicado en 2016

Phase 1, 2 and 3 trials in inflammatory bowel diseases: a practical guide for the non-specialist

artículo científico publicado en 2020

Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey

artículo científico publicado en 2018

Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines

artículo científico publicado en 2009

Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications

artículo científico publicado en 2004

Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients

artículo científico publicado en 2003

Point-of-care ultrasound in Inflammatory Bowel Disease

scientific article published on 17 July 2020

Positioning Therapies in Ulcerative Colitis

scientific article published on 23 January 2020

Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.

artículo científico publicado en 2018

Positioning ustekinumab in Crohn's disease: from clinical evidence to clinical practice

artículo científico publicado en 2017

Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block

scientific article published on 13 February 2020

Predicting future disease course in Crohn's disease by colonoscopy or magnetic resonance: which is the crystal ball?

artículo científico publicado en 2015

Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study

artículo científico publicado en 2015

Predictors for short bowel syndrome in Crohn's disease

scientific article published on 14 September 2020

Preoperative magnetic resonance enterography in predicting findings and optimizing surgical approach in Crohn's disease

artículo científico publicado en 2013

Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome.

artículo científico publicado en 2016

Preventing Collateral Damage in Crohn's Disease: The Lémann Index

artículo científico publicado en 2016

Preventing disability in inflammatory bowel disease

artículo científico publicado en 2017

Preventing diverticulitis recurrence by selecting the right therapy for a complex disease

scientific article published on 11 September 2014

Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing

artículo científico

Prevention of Postoperative Recurrence in CD: Tailoring Treatment to Patient Profile

scientific article published on 01 January 2019

Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase

artículo científico publicado en 2011

Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection

artículo científico publicado en 2016

Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease

artículo científico publicado en 2015

Protecting patients with IBD during the COVID-19 pandemic

artículo científico publicado en 2020

Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis.

artículo científico publicado en 2007

Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive Patients

artículo científico publicado en 2019

Psychological Functioning of Patients With Inflammatory Bowel Disease

scientific article published on 01 August 2019

Publisher Correction: Crohn's disease

artículo científico publicado en 2020

Publisher Correction: Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis

scientific article published on 30 July 2020

Quality of Care in Ulcerative Colitis: A Modified Delphi Panel Approach

scientific article published on 03 July 2018

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II).

artículo científico publicado en 2017

Redox equilibrium in mucosal T cells tunes the intestinal TCR signaling threshold

artículo científico publicado en 2005

Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology

artículo científico publicado en 2015

Regulatory T-Cell Therapy for Crohn's Disease: In Vivo Veritas

scientific article published on 20 September 2012

Reply

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

scholarly article by Matthieu Allez et al published October 2010 in Journal of Crohn's and Colitis

Response

scientific article published on 19 June 2020

Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease

artículo científico

Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment

artículo científico

Review article: faecal calprotectin and histologic remission in ulcerative colitis

artículo científico publicado en 2020

Review article: infliximab for Crohn’s disease treatment - shifting therapeutic strategies after 10 years of clinical experience ⬇️

artículo científico publicado el 15 de febrero de 2011

Review article: inherited thrombophilia in inflammatory bowel disease

artículo científico publicado en 2003

Review article: treating-to-target for inflammatory bowel disease-associated anaemia

artículo científico publicado en 2018

Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis

artículo científico publicado en 2020

Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation

artículo científico publicado en 2016

Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease

artículo científico publicado en 2012

Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study

artículo científico publicado en 2015

Risk of postoperative recurrence and postoperative management of Crohn's disease

artículo científico publicado en 2011

Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease.

artículo científico publicado en 2013

Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms' ⬇️

artículo científico publicado el 6 de enero de 2011

Roseburia hominis: a novel guilty player in ulcerative colitis pathogenesis?

artículo científico publicado en 2013

SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience

artículo científico publicado en 2020

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

artículo científico publicado en 2020

Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis

artículo científico publicado en 2014

Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis

scientific article published on 09 January 2020

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

scientific article published on 23 September 2020

Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses

artículo científico publicado en 2018

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

artículo científico publicado en 2017

Safety of vedolizumab in liver transplant recipients: A systematic review

artículo científico publicado en 2019

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations

artículo científico

Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects?

artículo científico

Setting up a Virtual Calprotectin Clinic in Inflammatory Bowel Diseases: Literature Review and Nancy Experience

artículo científico publicado en 2020

Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men.

artículo científico publicado en 2018

Short-term outcomes of laparoscopy combined with enhanced recovery pathway after ileocecal resection for Crohn's disease: a case-matched analysis

artículo científico publicado en 2012

Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?

artículo científico publicado en 2018

Statins and inflammatory bowel disease: Where do we stand?

artículo científico publicado en 2020

Step-up and top-down approaches to the treatment of Crohn's disease: early may already be too late

scientific article published on 04 September 2008

Stopping infliximab in Crohn’s disease: still an ongoing STORI

artículo científico publicado en 2012

Su1339 Ulcerative Colitis (UC) Diagnosed Over Age 65 Years -An IG-IBD Study

Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use

scientific article published on 01 August 2008

Successful treatment of fistulizing Crohn's disease with certolizumab pegol

scientific article published on 01 February 2008

Surgical conduct in case of intraoperative detection of a Meckel's diverticulum in Crohn's disease

artículo científico publicado en 2011

Surgical rates in the era of biological therapy: up, down or unchanged?

artículo científico publicado en 2017

Systematic review on IBD patients with COVID-19: it is time to take stock

artículo científico publicado en 2020

Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease

artículo científico publicado en 2020

Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis

artículo científico publicado en 2017

TNF inhibitors and risk of malignancy in patients with inflammatory bowel diseases: a systematic review

scientific article published on 11 September 2020

TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.

artículo científico publicado en 2006

TNFα inhibitors restrict T cell activation and cycling via Notch-1 signalling in inflammatory bowel disease.

artículo científico publicado en 2011

TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice

artículo científico publicado en 2017

Targeting S1P in Inflammatory bowel disease: new avenues for modulating intestinal leukocyte migration

artículo científico publicado en 2017

Targeting SMAD7 in Crohn’s Disease by Mongersen: Therapeutic Revolution Under Way?

artículo científico publicado en 2015

Targeting lymphatics in inflammatory bowel disease

artículo científico publicado en 2015

Targeting the gut layers in Crohn's disease: mucosal or transmural healing?

artículo científico publicado en 2020

Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!

artículo científico publicado en 2018

The Crohn's Disease-Ulcerative Colitis Clinical Appraisal

artículo científico publicado en 2016

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

scientific article published on 01 February 2020

The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy

scientific article published on 01 February 2019

The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.

artículo científico publicado en 2017

The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients

artículo científico publicado en 2020

The biosimilar road in inflammatory bowel disease: the right way?

artículo científico publicado en 2014

The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes

artículo científico publicado en 2016

The day after COVID-19 in IBD: how to go back to 'normal'

artículo científico publicado en 2020

The expanding therapeutic armamentarium for inflammatory bowel disease: how to choose the right drug(s) for our patients?

artículo científico publicado en 2017

The experience with biosimilars of infliximab in inflammatory bowel disease.

artículo científico publicado en 2017

The gut virome in inflammatory bowel disease pathogenesis: From metagenomics to novel therapeutic approaches

artículo científico publicado en 2019

The impact of biologics in surgical outcomes in ulcerative colitis

artículo científico publicado en 2018

The nocebo effect: a clinical challenge in the era of biosimilars

artículo científico publicado en 2018

The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications ⬇️

artículo científico publicado en 2009

The role of JAM-A in inflammatory bowel disease: unrevealing the ties that bind

artículo científico publicado en 2009

The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease.

artículo científico publicado en 2009

The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies

scientific article published on 19 June 2019

The role of magnetic resonance imaging in detecting intestinal fibrosis in Crohn's disease

artículo científico

The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort study

scientific article published on 18 September 2018

The safety of biological pharmacotherapy for the treatment of ulcerative colitis.

artículo científico publicado en 2017

The safety of vedolizumab for ulcerative colitis and Crohn's disease

artículo científico publicado en 2016

The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13.

artículo científico

The trend of C-Reactive protein allows a safe early discharge after surgery for Crohn's disease

artículo científico publicado en 2020

The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis

artículo científico publicado en 2014

The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation

scientific article published on 21 May 2014

The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper

artículo científico publicado en 2014

Thiopurines and non-melanoma skin cancer: partners in crime in inflammatory bowel diseases

artículo científico publicado en 2020

Thiopurines' Metabolites and Drug Toxicity: A Meta-Analysis

scientific article published on 13 July 2020

Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events

scientific article published on 01 January 2003

Thrombosis in IBD in the era of JAK inhibition

artículo científico publicado en 2020

Time to include patients with ulcerative proctitis in clinical trials

scientific article published on 01 December 2019

Timely Use of Biologics in Early Crohn's Disease: The Return of "Hit Hard and Early"?

scientific article published on 01 November 2019

Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis

scientific article published on 10 September 2018

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

artículo científico publicado en 2017

Tofacitinib for Acute Severe Colitis: When the going Gets Tough, the Tough Get Going

artículo científico publicado en 2020

Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience.

artículo científico publicado en 2019

Tofacitinib: janus bifrons in ulcerative colitis treatment

artículo científico publicado en 2013

Tolerogenic dendritic cells: cytokine modulation comes of age.

artículo científico publicado en 2006

Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review

scientific article published on 17 July 2020

Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

artículo científico publicado en 2014

Transmural Histological Scoring Systems in Crohn's Disease: A Systematic Review With Assessment of Methodological Quality and Operating Properties

scientific article published on 27 January 2020

Treat to target in mild to moderate ulcerative colitis: evidence to support this strategy

artículo científico publicado en 2020

Treat to target or "treat to clear" in inflammatory bowel diseases: one step further?

artículo científico publicado en 2020

Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience

artículo científico publicado en 2017

Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience

scientific article published on 01 April 2019

Treatment of perianal fistulas in Crohn's disease, seton versus anti-TNF versus surgical closure following anti-TNF (PISA): a randomised controlled trial

scientific article published on 10 January 2020

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

artículo científico publicado en 2010

Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization

scientific article published on 01 October 2016

Treatments for Crohn’s Disease–Associated Bowel Damage: A Systematic Review

artículo científico publicado en 2018

Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balance.

artículo científico publicado en 2007

Ulcerative Colitis

Ulcerative Colitis and Crohn's Disease Have the Same Burden and Goals for Treatment

artículo científico publicado en 2019

Ulcerative colitis

scientific article published on 10 September 2020

Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation

artículo científico publicado en 2011

Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease

scientific journal article

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus

scientific article published on 06 February 2019

Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus

scientific article published on 02 September 2019

Unmet Needs in IBD: the Case of Fatigue.

artículo científico publicado en 2017

Upadacitinib for Crohn's disease and ulcerative colitis treatment: hitting the selective JAKpot

artículo científico publicado en 2020

Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1.

artículo científico publicado en 2015

Use of Cross-Sectional Imaging for Tight Monitoring of Inflammatory Bowel Diseases

artículo científico publicado en 2019

Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

scientific article published on 19 February 2019

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease

article

Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis: Ustekinumab PK and exposure-response in UC

artículo científico publicado en 2019

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

artículo científico publicado en 2019

Ustekinumab for extra-intestinal manifestations of inflammatory bowel disease: a systematic literature review

scientific article published on 24 December 2020

Ustekinumab for treating ulcerative colitis: an expert opinion

artículo científico publicado en 2020

Ustekinumab in the management of Crohn's disease: Expert opinion.

artículo científico publicado en 2018

Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy

artículo científico publicado en 2020

VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.

artículo científico publicado en 2008

VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease

artículo científico publicado en 2014

Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis

artículo científico publicado en 2017

Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.

artículo científico publicado en 2013

Validation of the Red Flags Index for Early Diagnosis of Crohn's Disease: A Prospective Observational IG-IBD Study Among General Practitioners

scientific article published on 28 September 2020

Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal

artículo científico publicado en 2017

Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.

artículo científico publicado en 2015

Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects

artículo científico publicado en 2008

Vedolizumab Efficacy, Safety, and Pharmacokinetics with Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients with Crohn's Disease or Ulcerative Colitis

artículo científico publicado en 2020

Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review

scientific article published on 01 December 2019

Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis

scientific article published on 01 August 2019

Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?

artículo científico publicado en 2020

Vedolizumab as induction and maintenance therapy for ulcerative colitis

artículo científico publicado en 2013

Vedolizumab for the treatment of Crohn's disease.

artículo científico publicado en 2018

Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing

artículo científico publicado en 2019

Vedolizumab treatment persistence and safety in a 2-year data analysis of an extended access programme

artículo científico publicado en 2020

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

artículo científico publicado en 2019

Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery

artículo científico publicado en 2020

Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme

scientific article published on 09 October 2019

Viewpoint: Knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis Organization

artículo científico publicado en 2014

Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey

scientific article published on 13 May 2020

WallFlex colonic stent placement for management of malignant colonic obstruction: a prospective study at two centers

artículo científico publicado en 2008

What’s hot in inflammatory bowel disease in 2011? ⬇️

artículo científico publicado el 7 de febrero de 2011

Which MRI Score and Technique Should Be Used for Assessing Crohn's Disease Activity?

artículo científico publicado en 2020

mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease

artículo científico publicado en 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda